BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

NEUROTRAUMA SCIENCES, LLC — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Termination

NEUROTRAUMA SCIENCES, LLC

via THORN RUN PARTNERS

1st Quarter (Jan 1 - Mar 31) · 2025Posted Apr 17, 2025Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: NEUROTRAUMA SCIENCES, LLC
Description: Biotech Company
Location: Georgia · United States of America

Registrant

Firm: THORN RUN PARTNERS
Description: Government Affairs Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Budget/Appropriations
Monitor FY25 House and Senate Appropriations.
Lobbyistsmr SCOTT TOMINOVICH
Covered position (mr SCOTT TOMINOVICH): SA - Rep. Hoyer

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.